Dr. Jakob Rudzki, one of the most experienced CAR-T-cell therapy users in Austria, offers great experience in the field of innovative cell therapy at the Oberwart clinic and therefore gives patients serious hematological disorders.
A panacea for cancer has not yet been invented, but a state -of the -art form of therapy that is now also offered through the Oberwart Clinic gives serious hope in Germany. We are talking about the so-called Car-T cell therapy, which is used in patients with hematological disorders in which a different therapy has not hit.
Genetically modified cells
During this treatment, the defense cells of the body are genetically changed and then focused on cancer cells. For the fact that this treatment – which is usually administered as a one -off infusion – can now also be used in Burgenland, one is a senior doctor Dr. Jakob Rudzki owed. It is considered one of the most experienced CAR-T-Celtheater users in Austria, is co-founder of the Austrian network and has been active in the Oberwart clinic for several months, where the establishment of a separate department for oncology and palliative medicine has responded to the increasing number of cancer.
Top medicine near the place of residence
Governor Hans Peter Doskozil emphasizes the importance of the department: “Cancer is one of the biggest challenges of our time. The department for oncology and palliative medicine led by Prim. Univ. Prof. Dr. Martin Pichler is a good example of this, so that the safety of care and treatment was raised to a new level.”
For the use of Car-T cell therapy you work closely together in the Oberwart clinic with eight centers. Provisional investigations and aftercare take place in Oberwart, therapy in one of the certified centers, Dr. Rudzki.
In addition, the Oberwart clinic relies on the use of bisbecifical antibodies – a form of immunotherapy that also has a targeted effect on blood cancer. “With the therapy, the person involved opens the possibility of a very long reaction or in some cases even on healing,” Dr. emphasizes. Rudzki. This is the case with about half of the patients.
Source: Krone
I am an experienced and passionate journalist with a strong track record in news website reporting. I specialize in technology coverage, breaking stories on the latest developments and trends from around the world. Working for Today Times Live has given me the opportunity to write thought-provoking pieces that have caught the attention of many readers.
